Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress
Business Wire•28/10/2026•06:30 ET
0
Key Highlights
- ➤COMP360 Phase 3 encore posters cover efficacy, safety and participant demographics in TRD
- ➤Compass will present TRD education campaign Change the Tune at 2026 NEI Fall Congress
- ➤Congress participation scheduled November 5-8 in Colorado Springs, Colorado
- ➤COMP360 remains investigational for TRD and PTSD, with FDA Breakthrough Therapy designation
Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress
* Disease education booth underscores continued commitment to advancing understanding of treatment-resistant depression (TRD) among U.S. healthcare professionals (HCPs)
Get started
Create a free account to read the full story.